Cargando…

MicroRNA-155 regulates casein kinase 1 gamma 2: a potential pathogenetic role in chronic lymphocytic leukemia

Detalles Bibliográficos
Autores principales:	Zhang, T, Davidson-Moncada, J K, Mukherjee, P, Furman, R R, Bhavsar, E, Chen, Z, Hakimpour, P, Papavasiliou, N, Tam, W
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2017
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5709749/ https://www.ncbi.nlm.nih.gov/pubmed/28885613 http://dx.doi.org/10.1038/bcj.2017.80

Ejemplares similares

Distinct molecular genetics of chronic lymphocytic leukemia in Taiwan: clinical and pathogenetic implications
por: Wu, Shang-Ju, et al.
Publicado: (2017)

Signal Transducer and Activator of Transcription–3 Induces MicroRNA-155 Expression in Chronic Lymphocytic Leukemia
por: Li, Ping, et al.
Publicado: (2013)

Casein-Based Nanoparticles: A Potential Tool for the Delivery of Daunorubicin in Acute Lymphocytic Leukemia
por: Zahariev, Nikolay, et al.
Publicado: (2023)

MicroRNAs in rhabdomyosarcoma: pathogenetic implications and translational potentiality
por: Rota, Rossella, et al.
Publicado: (2011)

Intrinsic and extrinsic factors influencing the clinical course of B-cell chronic lymphocytic leukemia: prognostic markers with pathogenetic relevance
por: Dal-Bo, Michele, et al.
Publicado: (2009)

Advanced Pathogenetic Concepts in T-Cell Prolymphocytic Leukemia and Their Translational Impact
por: Braun, Till, et al.
Publicado: (2021)

The Pathogenetic Picture
por: Fincke, B.
Publicado: (1891)

Pathogenetic and diagnostic significance of microRNA deregulation in peripheral T-cell lymphoma not otherwise specified
por: Laginestra, M A, et al.
Publicado: (2014)

Total Proteome Analysis Identifies Migration Defects as a Major Pathogenetic Factor in Immunoglobulin Heavy Chain Variable Region (IGHV)-unmutated Chronic Lymphocytic Leukemia
por: Eagle, Gina L., et al.
Publicado: (2015)

Switch recombination and somatic hypermutation are controlled by the heavy chain 3′ enhancer region
por: Dunnick, Wesley A., et al.
Publicado: (2009)

MiR-155/miR-150 network regulates progression through the disease phases of chronic lymphocytic leukemia
por: Vargova, K, et al.
Publicado: (2017)

Welcome to PathoGenetics
por: Ballabio, Andrea, et al.
Publicado: (2008)

Notes, Clinical and Pathogenetic
por: Berridge, E. W.
Publicado: (1885)

On the Pathogenetic Effects of Malaria
por: Munson, W. G.
Publicado: (1864)

Clinical and Pathogenetic Notes
por: Berridge, E. W.
Publicado: (1884)

Clinical and Pathogenetic Notes
por: Berridge, E. W.
Publicado: (1891)

Cross section measurements of $^{155,157}$Gd(n,$\gamma$) induced by thermal and epithermal neutrons
por: Mastromarco, M., et al.
Publicado: (2018)

Role of microRNAs in Chronic Lymphocytic Leukemia
por: Autore, Francesco, et al.
Publicado: (2023)

MicroRNA-155-5p Overexpression in Peripheral Blood Mononuclear Cells of Chronic Lymphocytic Leukemia Patients Is a Novel, Independent Molecular Biomarker of Poor Prognosis
por: Papageorgiou, Sotirios G., et al.
Publicado: (2017)

The multiple roles of microRNA-155 in oncogenesis
por: Higgs, Gadareth, et al.
Publicado: (2013)

Casein kinase signaling in axon regeneration
por: Ayad, Nagi G., et al.
Publicado: (2016)

MicroRNA-155 expression with Brucella infection in vitro and in vivo and decreased serum levels of MicroRNA-155 in patients with brucellosis
por: Zhang, Xi, et al.
Publicado: (2022)

Sodium caseinate hinders chymosin-induced aggregation of caseins in concentrated milk: The role of soluble caseins and calcium ions
por: Krishnankutty Nair, P., et al.
Publicado: (2021)

Catecholamine cardiomyopathy: review and analysis of pathogenetic mechanisms.
por: Jiang, J. P., et al.
Publicado: (1990)

Measurement and analysis of $^{155,157}$Gd(n,$\gamma$) from thermal energy to 1 keV
por: Massimi, C, et al.
Publicado: (2020)

Remak's Diagnostic and Pathogenetic Investigations
Publicado: (1847)

The RASopathies: from pathogenetics to therapeutics
por: Hebron, Katie E., et al.
Publicado: (2022)

A Pathogenetic Materia Medica
Publicado: (1895)

Pathogenetic Action of High Potencies
por: Buchmann,
Publicado: (1883)

Combined Casein Kinase II inhibition and epigenetic modulation in acute B-lymphoblastic leukemia
por: Richter, Anna, et al.
Publicado: (2019)

Epigenetic regulation of gene expression by Ikaros, HDAC1 and Casein Kinase II in leukemia
por: Song, C, et al.
Publicado: (2016)

Gamma-Delta Large Granular Lymphocytic Leukemia: A Diagnostic Dilemma
por: Oye, Melissa, et al.
Publicado: (2022)

Alteration of Endothelins: A Common Pathogenetic Mechanism in Chronic Diabetic Complications
por: Chakrabarti, Subrata, et al.
Publicado: (2002)

MicroRNA-155 and Its Role in Malignant Hematopoiesis
por: Ranganath, Prajnya
Publicado: (2015)

The Emerging Role of MicroRNA-155 in Cardiovascular Diseases
por: Cao, Richard Y., et al.
Publicado: (2016)

The MicroRNA miR-155 Is Essential in Fibrosis
por: Eissa, Mousa G., et al.
Publicado: (2019)

MicroRNA-155: Regulation of Immune Cells in Sepsis
por: Chen, Ming, et al.
Publicado: (2021)

Epigenetic evolution and lineage histories of chronic lymphocytic leukemia
por: Gaiti, Federico, et al.
Publicado: (2019)

Serum microRNAs in male subfertility—biomarkers and a potential pathogenetic link to metabolic syndrome
por: Trzybulska, Dorota, et al.
Publicado: (2017)

MicroRNA Dysregulation in Epilepsy: From Pathogenetic Involvement to Diagnostic Biomarker and Therapeutic Agent Development
por: Wang, Jialu, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_h3tsdef513dsdovao7v5ap7cdk